US News Money Highlights Seven Biotech ETFs for Investor Consideration CWCO Q1 2026 Earnings EPS Misses Estimates Revenue Data Unavailable US Stock Futures and Bond Yields Slide on Reports of Putins Updated Nuclear Doctrine CalMaine Foods Q1 2026 Earnings EPS Beats Estimates by Nearly 30 as Egg Market Remains Favorable Myomo Q1 2026 Earnings EPS Surprises Positively Revenue Not Disclosed PACK Q1 2026 Earnings Narrowly Beats EPS Estimates Amid Challenging Environment GOVX Q1 2026 Earnings NarrowerthanExpected Loss as Biotech Advances Development RMBI Q1 2026 Earnings Modest EPS Amid Market Headwinds PAYP Q1 2026 Earnings Significant EPS Miss Weighs on Investor Sentiment PURR Q1 2026 Earnings Strong EPS Beat on Zero Revenue Estimate Highlights Profitability Focus Summit State Bank SSBI Q1 2026 Earnings Modest EPS Amid Quiet Quarter MRCC Q4 2025 Earnings EPS Surpasses Estimates by Nearly 20 Shares Unchanged Addex Therapeutics Q1 2024 Earnings Continued RD Spending Weighs on Bottom Line as Pipeline Progresses MEC Q1 2026 Earnings EPS Beat on NarrowerThanExpected Loss Legence Corp Q1 2026 Earnings EPS Misses Estimates as Company Faces Headwinds Primis Financial Corp FRST Q1 2026 Earnings EPS Surpasses Estimates by 142 Shares Edge Higher MLEC Q2 2025 Earnings Narrowed Loss Beats Estimates as Operational Progress Continues COYA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Reaction SGLY Q3 2019 Earnings Massive EPS Miss Highlights Operational Challenges